Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador

Background: Urinary tract infections (UTI) are among the most common infections in pediatric patients. The main etiopathogenic agent is Escherichia coli. The purpose of this study was to determine the antimicrobial resistance pattern of E. coli in pediatric patients and to understand their main clin...

Full description

Bibliographic Details
Main Authors: David Garrido, Santiago Garrido, Miguel Gutiérrez, Leonel Calvopiña, Amani Sunday Harrison, Michelle Fuseau, Ramiro Salazar Irigoyen
Format: Article
Language:English
Published: Permanyer 2017-07-01
Series:Boletín Médico del Hospital Infantil de México
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665114616301381
id doaj-37de1d09c64b40c091f83f8fb0880b2d
record_format Article
spelling doaj-37de1d09c64b40c091f83f8fb0880b2d2021-04-02T02:11:51ZengPermanyerBoletín Médico del Hospital Infantil de México1665-11462017-07-0174426527110.1016/j.bmhimx.2017.02.004Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, EcuadorDavid Garrido0Santiago Garrido1Miguel Gutiérrez2Leonel Calvopiña3Amani Sunday Harrison4Michelle Fuseau5Ramiro Salazar Irigoyen6Facultad de Ciencias Médicas, Universidad Central del Ecuador, Quito, EcuadorFacultad de Ciencias Médicas, Universidad Central del Ecuador, Quito, EcuadorServicio de Pediatría, Hospital de Especialidades de las Fuerzas Armadas N.° 1, Quito, EcuadorLaboratorio de Microbiología, Hospital de Especialidades de las Fuerzas Armadas N.° 1, Quito, EcuadorFacultad de Ciencias Médicas, Universidad Central del Ecuador, Quito, EcuadorHospital de Especialidades de las Fuerzas Armadas N.° 1, Quito, EcuadorLaboratorio de Microbiología, Facultad de Ciencias Médicas, Universidad Central del Ecuador, Quito, EcuadorBackground: Urinary tract infections (UTI) are among the most common infections in pediatric patients. The main etiopathogenic agent is Escherichia coli. The purpose of this study was to determine the antimicrobial resistance pattern of E. coli in pediatric patients and to understand their main clinical and laboratory manifestations. Methods: Fifty-nine patients were included in the study and classified into two groups: hospitalization (H) and external consultation (EC). Every patient presented urine cultures with the isolation of E. coli that included an antibiogram. Clinical signs and symptoms, urinalysis, complete blood count (CBC) and serum inflammatory markers were analyzed. Results: The most common clinical manifestations were fever (H: 76.5%; EC: 88%), vomiting (H: 32.4%; EC: 32%), hyporexia (H: 20.6%; EC: 16%), abdominal pain (H: 20.6%: EC: 28%), and dysuria (H: 14.7%; EC: 32%). Ten patients (16.95%) presented UTI for extended spectrum beta-lactamase (ESBL) E. coli. Ampicillin, nalidixic acid, and trimethoprim-sulfamethoxazole showed a higher resistance rate, being ampicillin the most significant (H: 88.2%; EC: 92%). Leukocyturia, bacteriuria and urine nitrites were frequent alterations in urinalysis (H: 52.9%; EC: 92%). In ESBL E. coli patients, a positive correlation was found between leukocytes in CBC and C-reactive protein (r = 0.9, p < 0.01). Diarrhea and foul-smelling urine were associated with E. coli resistance. Conclusions: The presence of leukocytes, bacteria, nitrites and the Gram stain are the most common indicators. Nitrofurantoin and phosphomycin are good therapeutic options. However, an antibiogram must be conducted to determine the best therapeutic agent.http://www.sciencedirect.com/science/article/pii/S1665114616301381Urinary tract infectionsPediatricsEscherichia coli
collection DOAJ
language English
format Article
sources DOAJ
author David Garrido
Santiago Garrido
Miguel Gutiérrez
Leonel Calvopiña
Amani Sunday Harrison
Michelle Fuseau
Ramiro Salazar Irigoyen
spellingShingle David Garrido
Santiago Garrido
Miguel Gutiérrez
Leonel Calvopiña
Amani Sunday Harrison
Michelle Fuseau
Ramiro Salazar Irigoyen
Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador
Boletín Médico del Hospital Infantil de México
Urinary tract infections
Pediatrics
Escherichia coli
author_facet David Garrido
Santiago Garrido
Miguel Gutiérrez
Leonel Calvopiña
Amani Sunday Harrison
Michelle Fuseau
Ramiro Salazar Irigoyen
author_sort David Garrido
title Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador
title_short Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador
title_full Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador
title_fullStr Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador
title_full_unstemmed Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador
title_sort clinical characterization and antimicrobial resistance of escherichia coli in pediatric patients with urinary tract infection at a third level hospital of quito, ecuador
publisher Permanyer
series Boletín Médico del Hospital Infantil de México
issn 1665-1146
publishDate 2017-07-01
description Background: Urinary tract infections (UTI) are among the most common infections in pediatric patients. The main etiopathogenic agent is Escherichia coli. The purpose of this study was to determine the antimicrobial resistance pattern of E. coli in pediatric patients and to understand their main clinical and laboratory manifestations. Methods: Fifty-nine patients were included in the study and classified into two groups: hospitalization (H) and external consultation (EC). Every patient presented urine cultures with the isolation of E. coli that included an antibiogram. Clinical signs and symptoms, urinalysis, complete blood count (CBC) and serum inflammatory markers were analyzed. Results: The most common clinical manifestations were fever (H: 76.5%; EC: 88%), vomiting (H: 32.4%; EC: 32%), hyporexia (H: 20.6%; EC: 16%), abdominal pain (H: 20.6%: EC: 28%), and dysuria (H: 14.7%; EC: 32%). Ten patients (16.95%) presented UTI for extended spectrum beta-lactamase (ESBL) E. coli. Ampicillin, nalidixic acid, and trimethoprim-sulfamethoxazole showed a higher resistance rate, being ampicillin the most significant (H: 88.2%; EC: 92%). Leukocyturia, bacteriuria and urine nitrites were frequent alterations in urinalysis (H: 52.9%; EC: 92%). In ESBL E. coli patients, a positive correlation was found between leukocytes in CBC and C-reactive protein (r = 0.9, p < 0.01). Diarrhea and foul-smelling urine were associated with E. coli resistance. Conclusions: The presence of leukocytes, bacteria, nitrites and the Gram stain are the most common indicators. Nitrofurantoin and phosphomycin are good therapeutic options. However, an antibiogram must be conducted to determine the best therapeutic agent.
topic Urinary tract infections
Pediatrics
Escherichia coli
url http://www.sciencedirect.com/science/article/pii/S1665114616301381
work_keys_str_mv AT davidgarrido clinicalcharacterizationandantimicrobialresistanceofescherichiacoliinpediatricpatientswithurinarytractinfectionatathirdlevelhospitalofquitoecuador
AT santiagogarrido clinicalcharacterizationandantimicrobialresistanceofescherichiacoliinpediatricpatientswithurinarytractinfectionatathirdlevelhospitalofquitoecuador
AT miguelgutierrez clinicalcharacterizationandantimicrobialresistanceofescherichiacoliinpediatricpatientswithurinarytractinfectionatathirdlevelhospitalofquitoecuador
AT leonelcalvopina clinicalcharacterizationandantimicrobialresistanceofescherichiacoliinpediatricpatientswithurinarytractinfectionatathirdlevelhospitalofquitoecuador
AT amanisundayharrison clinicalcharacterizationandantimicrobialresistanceofescherichiacoliinpediatricpatientswithurinarytractinfectionatathirdlevelhospitalofquitoecuador
AT michellefuseau clinicalcharacterizationandantimicrobialresistanceofescherichiacoliinpediatricpatientswithurinarytractinfectionatathirdlevelhospitalofquitoecuador
AT ramirosalazaririgoyen clinicalcharacterizationandantimicrobialresistanceofescherichiacoliinpediatricpatientswithurinarytractinfectionatathirdlevelhospitalofquitoecuador
_version_ 1724174569028190208